Asset Details
Do you wish to reserve the book?
Cross-sectional human immunodeficiency virus incidence estimation accounting for heterogeneity across communities
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Cross-sectional human immunodeficiency virus incidence estimation accounting for heterogeneity across communities
Do you wish to request the book?
Cross-sectional human immunodeficiency virus incidence estimation accounting for heterogeneity across communities
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Cross-sectional human immunodeficiency virus incidence estimation accounting for heterogeneity across communities
2019
Overview
Accurate estimation of human immunodeficiency virus (HIV) incidence rates is crucial for the monitoring of HIV epidemics, the evaluation of prevention programs, and the design of prevention studies. Traditional cohort approaches to measure HIV incidence require repeatedly testing large cohorts of HIV-uninfected individuals with an HIV diagnostic test (eg, enzyme-linked immunosorbent assay) for long periods of time to identify new infections, which can be prohibitively costly, time-consuming, and subject to loss to follow-up. Cross-sectional approaches based on the usual HIV diagnostic test and biomarkers of recent infection offer important advantages over standard cohort approaches, in terms of time, cost, and attrition. Cross-sectional samples usually consist of individuals from different communities. However, small sample sizes limit the ability to estimate community-specific incidence and existing methods typically ignore heterogeneity in incidence across communities. We propose a permutation test for the null hypothesis of no heterogeneity in incidence rates across communities, develop a random-effects model to account for this heterogeneity and to estimate community-specific incidence, and provide one way to estimate the coefficient of variation. We evaluate the performance of the proposed methods through simulation studies and apply them to the data from the National Institute of Mental Health Project ACCEPT, a phase 3 randomized controlled HIV prevention trial in Sub-Saharan Africa, to estimate the overall and community-specific HIV incidence rates.
Publisher
Wiley Subscription Services, Inc,Blackwell Publishing Ltd
Subject
/ biometry
/ enzyme-linked immunosorbent assay
/ Epidemics - prevention & control
/ HIV
/ HIV - isolation & purification
/ HIV Infections - epidemiology
/ HIV Infections - prevention & control
/ Human immunodeficiency virus
/ Humans
/ Mass Screening - statistics & numerical data
/ Population Groups - statistics & numerical data
/ Residence Characteristics - statistics & numerical data
/ Viruses
